A model for Batten disease protein CLN3: functional implications from homology and mutations

FEBS Letters
R B JanesB A Wallace

Abstract

In an attempt to understand the molecular nature of Batten disease, we have examined the amino acid sequence of the affected CLN3 gene product (The International Batten Disease Consortium (1995) Cell 82, 949-957) and the site-specific mutations which give rise to the biological defect. Homology searches and molecular modeling have led to the development of a model for the folding and disposition of the protein, possibly within a mitochondrial membrane. High homology with a yeast protein of unknown function suggests a strong evolutionary conservation of function. We speculate that a possible role for the protein may be in chaperoning the folding/unfolding or assembly/ disassembly of other proteins, specifically subunit c of the mitochondrial ATP synthase complex.

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Nov 25, 1988·Nucleic Acids Research·F Corpet
Jan 1, 1988·Brain & Development·P Santavuori
Jan 1, 1986·Annual Review of Biophysics and Biophysical Chemistry·D M EngelmanA Goldman
Dec 9, 1983·Science·R Wolfenden
May 5, 1982·Journal of Molecular Biology·J Kyte, R F Doolittle
Feb 15, 1996·Nature·D E BassettP Hieter
Feb 1, 1996·Biochemical and Molecular Medicine·A J Tanner, J F Dice
Feb 19, 2002·Neurochemistry International·R D JollyS U Walkley

❮ Previous
Next ❯

Citations

Dec 31, 2003·Molecular Biology of the Cell·Aija KyttäläJ Paul Luzio
Feb 28, 1998·Human Molecular Genetics·I JärveläA Jalanko
Aug 14, 1999·Epilepsia·S Mole, M Gardiner
Jul 9, 2004·Pediatric Research·Dixie-Ann Persaud-SawinRose-Mary N Boustany
Jul 23, 2014·PloS One·Ewa RatajczakMika O Ruonala
Mar 5, 2004·Brain Pathology·Sara E Mole
Aug 1, 1997·American Journal of Human Genetics·P B MunroeS E Mole
Sep 26, 2000·Molecular Genetics and Metabolism·N Zhong
Jul 15, 2006·Biochimica Et Biophysica Acta·Aija KyttäläSandra L Hofmann
Apr 7, 1999·Molecular Genetics and Metabolism·K L PuranamR M Boustany
Apr 7, 1999·Molecular Genetics and Metabolism·R E HaskellB L Davidson
Apr 7, 1999·Molecular Genetics and Metabolism·T KlockarsL Peltonen
Apr 7, 1999·Molecular Genetics and Metabolism·W KaczmarskiM Michalewski
Sep 6, 2014·Frontiers in Cellular Neuroscience·Megan Bosch, Tammy Kielian
Mar 9, 1999·Neurobiology of Disease·S E Mole
Jan 29, 2013·Experimental Biology and Medicine·Tianwei LiShyh-Ching Lo
Oct 2, 2001·American Journal of Medical Genetics·A V Delgado-EscuetaK Yamakawa
Apr 23, 2003·FEBS Letters·Qinwen MaoBeverly L Davidson
Mar 21, 2019·The International Journal of Neuroscience·Muhammad SherShahid Mahmood Baig
Oct 1, 2019·Molecular Genetics & Genomic Medicine·Myriam MirzaDanielle M Kerkovich
Nov 28, 2001·Current Opinion in Neurology·H M Mitchison, S E Mole
Feb 11, 1998·Brain Pathology·H H Goebel, J D Sharp
Jun 23, 2000·Journal of Inherited Metabolic Disease·G M ManciniF W Verheijen
Nov 4, 2020·International Journal of Molecular Sciences·Elena K Shematorova, George V Shpakovski
Apr 7, 1999·Molecular Genetics and Metabolism·M P MichalewskiK E Wisniewski
Jan 20, 2005·Journal of Neuroscience Research·Seasson N PhillipsDavid A Pearce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.